Spinal
cord organoids are of significant value in the research
of spinal cord-related diseases by simulating disease states, thereby
facilitating the development of novel therapies. However, the complexity
of spinal cord structure and physiological functions, along with the
lack of human-derived inducing components, presents challenges in
the in vitro construction of human spinal cord organoids. Here, we
introduce a novel human decellularized placenta-derived extracellular
matrix hydrogel (DPECMH) and, combined with a new induction protocol,
successfully construct human spinal cord organoids. The human placenta-sourced
decellularized extracellular matrix (dECM), verified through hematoxylin
and eosin staining, DNA quantification, and immunofluorescence staining,
retained essential ECM components such as elastin, fibronectin, type
I collagen, laminin, and so forth. The temperature-sensitive hydrogel
made from human placenta dECM demonstrated good biocompatibility and
promoted the differentiation of human induced pluripotent stem cell
(hiPSCs)-derived spinal cord organoids into neurons. It displayed
enhanced expression of laminar markers in comparison to Matrigel and
showed higher expression of laminar markers compared to Matrigel,
accelerating the maturation process of spinal cord organoids and demonstrating
its potential as an organoid culture substrate. DPECMH has the potential
to replace Matrigel as the standard additive for human spinal cord
organoids, thus advancing the development of spinal cord organoid
culture protocols and their application in the in vitro modeling of
spinal cord-related diseases.